Product Update - May 16th, 2022

New Features & Enhancements

  • SDP Users Can Enjoy SSO Simplicity and with Security of Never-Off/Always-On: Cato Clients now support the ability to authenticate with Single Sign-On (SSO) and at same time the Client Access Connectivity policy is set to Never-Off for Windows and Always-On for macOS. Read more.
    • Minimum supported Client versions are Windows Client v5.3, and macOS Client v5.0
    • You can configure SSO and Never-Off/Always-On for the entire account or for specific SDP users 
  • New Anti-Malware Allowlist: We are enhancing the Anti-Malware policy with a new Allowlist screen that lets you easily define rules to bypass Anti-Malware scans (Security > Anti-Malware > Allowlist). For example, you can allowlist traffic for sensitive devices that can experience issues with these scans. Read more.
    • The Allowlist rules are applied to the Anti-Malware engines before the Protection Policy rules
    • For accounts that aren’t experiencing issues with Anti-Malware scans, it’s not necessary to create new allowlist rules
  • Enhancement for LDAP Directory Services: You can select the AD Provider for LDAP services in the Cato Managment Application (Access > Directory Services > Edit Directory Service). Read more.

Security Updates

  • IPS Signatures:
    • Malware - Rclone (New)
    • Malware - Lockbit (Enhancement)
    • CVE-2022-29464
    • CVE-2022-26925
    • CVE-2022-1388
    • CVE-2021-30116
    • CVE-2020-8816
    • CVE-2020-4006
    • CVE-2020-2555
    • CVE-2019-3929
    • CVE-2018-7602
    • CVE-2018-0798
    • CVE-2018-0171
    • CVE-2017-11512
    • CVE-2010-5330
    • CVE-2007-3010
  • Application Database:
    • DNS over HTTPS - DoH (Enhancement)
  • Application Control Policy:
    • Gmail - Add attachment (Enhancement)
    • OneDrive Business & SharePoint – Download (Enhancement)
    • OneDrive Personal – Download (Enhancement)
    • Skype and MS Teams - Upload (Enhancement)

Knowledge Base Updates

Was this article helpful?

0 out of 0 found this helpful

0 comments

Add your comment